Santhera Pharmaceuticals Holding AG (SPHDF) Financials

SPHDF Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 186.7 million 201.6 million
June 30, 2025 164.9 million 168.2 million
Dec. 31, 2024 168.6 million 138.0 million
June 30, 2024 120.2 million 66.8 million

SPHDF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -17.9 million ?
June 30, 2025 -26.1 million 2.9 million
Dec. 31, 2024 -22.5 million ?
June 30, 2024 -17.1 million 2.9 million

SPHDF Net Income

No data available :(

SPHDF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 28.3 million 91.6 million 1.7 million
June 30, 2025 23.2 million 40.5 million 2.8 million
Dec. 31, 2024 45.3 million 35.1 million 2.8 million
June 30, 2024 18.3 million - 3.0 million

SPHDF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 16.9 million
June 30, 2025 16.1 million
Dec. 31, 2024 12.6 million
June 30, 2024 12.6 million

SPHDF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 65570 13.3 million 18.6 million -
June 30, 2025 89549 14.7 million 19.7 million 8.6 million
Dec. 31, 2024 87358 14.0 million 19.1 million 7.0 million
June 30, 2024 79964 15.3 million 14.4 million 5.2 million

SPHDF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 67.0 million 38.1 million
June 30, 2025 30.3 million 40.5 million
Dec. 31, 2024 27.6 million 11.8 million
June 30, 2024 15.7 million 5.8 million

SPHDF

Price: $23.25

52 week price:
12.28
23.25

Earnings Per Share: -4.79 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 337.7 million

Links: